Literature DB >> 10768214

Steroid-induced osteoporosis in systemic lupus erythematosus.

G Cunnane1, N E Lane.   

Abstract

The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid-induced osteoporosis in SLE and outlines strategies for prevention and treatment.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10768214     DOI： 10.1016/s0889-857x(05)70140-x

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  6 in total

1.  Bone geometry profiles in women with and without SLE.

Authors:  Jimmy D Alele; Diane L Kamen; Kelly J Hunt; Rosalind Ramsey-Goldman
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

2.  Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis.

Authors:  Kofi A Mensah; Alexis Mathian; Lin Ma; Lianping Xing; Christopher T Ritchlin; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2010-04

3.  Vitamin D deficiency in patients with active systemic lupus erythematosus.

Authors:  V Z C Borba; J G H Vieira; T Kasamatsu; S C Radominski; E I Sato; M Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2008-07-04       Impact factor: 4.507

4.  Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation.

Authors:  Tohid Hassanalilou; Leila Khalili; Saeid Ghavamzadeh; Ali Shokri; Laleh Payahoo; Yaser Khaje Bishak
Journal:  Auto Immun Highlights       Date:  2017-12-26

5.  The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.

Authors:  Izabela Korczowska; Anna Olewicz-Gawlik; Paweł Hrycaj; Jan Lacki
Journal:  Yale J Biol Med       Date:  2003

Review 6.  Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?

Authors:  Jacqueline K Flynn; Wendy Dankers; Eric F Morand
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.